Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 <sup>+</sup> Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic LeukemiaJean‐Baptiste Robin, Hugo Bergugnat, Éolia Brissot et al.|Journal of Clinical Oncology|2024Cited by 33
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies: Insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Nicolas Duployez, Pascal Huchette et al.|Blood|2025Cited by 0